ResMed

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. 

CEO
Michael J. Farrell
CEOMichael J. Farrell
Employees
11,370
Employees11,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
11,370
Employees11,370

RMD Key Statistics

Market cap
32.46B
Market cap32.46B
Price-Earnings ratio
21.57
Price-Earnings ratio21.57
Dividend yield
1.09%
Dividend yield1.09%
Average volume
1.45M
Average volume1.45M
High today
$228.38
High today$228.38
Low today
$224.56
Low today$224.56
Open price
$227.65
Open price$227.65
Volume
3.86M
Volume3.86M
52 Week high
$284.87
52 Week high$284.87
52 Week low
$180.27
52 Week low$180.27

Stock Snapshot

The current ResMed(RMD) stock price is $224.99, with a market capitalization of 32.46B. The stock trades at a price-to-earnings (P/E) ratio of 21.57 and offers a dividend yield of 1.09%.

As of 2026-09-20, ResMed(RMD) stock has fluctuated between $224.56 and $228.38. The current price stands at $224.99, placing the stock +0.2% above today's low and -1.5% off the high.

ResMed(RMD) shares are trading with a volume of 3.86M, against a daily average of 1.45M.

In the last year, ResMed(RMD) shares hit a 52-week high of $284.87 and a 52-week low of $180.27.

In the last year, ResMed(RMD) shares hit a 52-week high of $284.87 and a 52-week low of $180.27.

RMD News

MarketWatch 2d
ResMed Inc. stock falls Friday, underperforms market - MarketWatch

...

ResMed Inc. stock falls Friday, underperforms market - MarketWatch
Simply Wall St 4d
Learn Why The Bull Case For ResMed Stock Could Change Following Earnings Beat

ResMed reported Q4 2026 results with revenue of $1.46b, up 8.6% year on year, and an adjusted EPS beat alongside operating margin pressure from higher R&D and s...

Learn Why The Bull Case For ResMed Stock Could Change Following Earnings Beat
Barron's 5d
Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.

You are now leaving Barron's website By clicking on the “Proceed” button below, you will be redirected to a third-party website owned and operated by Hong Kong...

Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.

Analyst ratings

60%

of 30 ratings
Buy
60%
Hold
30%
Sell
10%

More RMD News

TipRanks 5d
ResMed upgraded to Outperform from Sector Perform at RBC Capital

RBC Capital analyst Craig Wong-Pan upgraded ResMed (RMD) to Outperform from Sector Perform with a price target of $262, up from $244. The company will continue...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.